Press Release

Nucleic Acid Testing Market to Witness Steady Growth as Demand from Blood Banks Increases

Nucleic Acid Testing Market, conveys rigorous analysis of Industry and prospects to 2026: Fortune Business Insights

The Global Nucleic Acid Testing Market is slated for rapid growth owing to the increasing demand for nucleic acid kits from blood transfusion centers and blood banks. Crucial insights into this developing market have been shared by Fortune Business Insights in its report, titled “Nucleic Acid Testing Market Size, Share and Global Trend By Technology (Polymerase Chain Reaction, Ligase Chain Reaction, Transcription-mediated Amplification, Whole Genome Sequencing), By Application (Disease Diagnosis, Forensic Testing, Personalized Medicine, Others), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes), and Geography Forecast Till 2026”.

The report enunciates the influential factors driving the growth of this emerging market. Nucleic acids are essentially molecules carrying genetic information that is passed down from parents to their children.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

  • Abbott
  • BD
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Illumina
  • Siemens Healthineers
  • Hologic, Inc.
  • bioMérieux SA
  • Novartis
  • F. Hoffmann-La Roche Ltd.
  • Sequenom
  • Tecan Trading AG.

Rising Investments in Research Intensifying Competition in the Market

Investments in research by private healthcare organizations and companies is expected to the fuel the global nucleic acid testing market during the forecast period. The market is also witnessing increasing competition with companies pulling all stops to diversify their product portfolios. For example, the NALFIA rapid detection test for detecting DIG/Biotin and/or FITC Biotin-labelled analytes was launched by Abingdon Health in early 2019. About six months prior to Abingdon, scientists at the National University of Singapore developed ‘enVision’, a portable point-of-care nucleic acid test.

Segmentation:

By Technology

  • Polymerase Chain Reaction (PCR)
  • Ligase Chain Reaction (LCR)
  • Transcription-mediated Amplification (TMA)
  • Whole Genome Sequencing
  • Others

By Application

  • Disease Diagnosis
  • Forensic Testing
  • Personalized Medicine
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

More Trending Topics From Fortune Business [email protected]

Automotive Tire Market to Expand with Light Commercial Vehicles Production Set to Reach 118.9 Million Units by 2025: Fortune Business Insights

Feed Premix Market to Reach USD 15.35 Billion by 2026; Rising Technological Advancement to Boost Growth: Fortune Business Insights

Connected Cars Market to Exhibit a Staggering 26.4% CAGR; Driven by the Growing Incorporation of Machine Learning Algorithms, says Fortune Business Insights

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close